AutoCyte supplies more data on PREP:
This article was originally published in Clinica
Executive Summary
AutoCyte has presented more data to the FDA on its PREP sample preparation system as part of its PMA application for the device which automates the process of preparing cervical smear samples for analysis. The data includes further analysis of existing data to demonstrate sensitivity. The company submitted the original PMA application in May last year and expects to gain approval in the third quarter of 1998.